BRUCE WILLIAMS: Open Payments
NPI 1033215322 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 9 payments from 5 companies in 2025. Trend: 2023 $455 · 2024 $14 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 4 | $142 |
| Novo Nordisk Inc | 2 | $36 |
| Verona Pharma, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
Products named: ZORYVE, Rybelsus, Ohtuvayre, MOUNJARO, FARXIGA.
Industry payments across PA — which companies pay providers there.
